Mediclinic Intnl plc - AGM Trading Update
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
("Mediclinic", or the "Company" or the "Group")
2020 Annual General Meeting trading update
Demonstrating operational resilience
Ahead of its Annual General Meeting today, Mediclinic, the diversified international private healthcare services group, provides the following trading update for
At the FY20 results, Mediclinic reported on the sequential improvement between April and
As lockdown measures are relaxed, the gradual re-introduction of elective procedures and outpatient activities leads to improved operating performance.
The severity, duration and full impact of the COVID-19 pandemic and its economic aftermath on all businesses, including Mediclinic, continues to be uncertain. There remains a risk to elective procedures and outpatient activity from a continuation or reintroduction of lockdown and other measures in response to the pandemic; the availability of staff; and a disruption in the supply chain. Mediclinic is focused on fulfilling its vital role as a leading provider of essential healthcare services during this crisis. To this end, the Group remains agile in its approach, optimising its response to overcome challenges and create opportunities while seeking to maintain its strong financial position and liquidity.
Mediclinic currently expects to issue its 2021 half-year trading update on
Mediclinic is a diversified international private healthcare services group, established in
The Group's core purpose is to enhance the quality of life.
Its vision is to be the partner of choice that people trust for all their healthcare needs.
Mediclinic is focused on providing specialist-orientated, multi-disciplinary services across the continuum of care in such a way that the Group will be regarded as the most respected and trusted provider of healthcare services by patients, medical practitioners, funders and regulators of healthcare in each of its markets.
The Company's primary listing is on the
Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, a leading private healthcare group based in the
For further information, please contact:
+44 (0)20 7954 9548
+44 (0)20 3786 8181
+44 (0)20 3727 1000
+27 (0)21 487 9000
Registered address: 6th Floor,
Corporate broker (
JSE sponsor (
NSX sponsor (
This information is provided by RNS, the news service of the